Diagnostic and Biotech

Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019

  • TEC280094
  • 84 Pages
  • August 2015
  • Diagnostic and Biotech

About Chronic Lymphocytic Leukemia 

Chronic lymphocytic leukemia is a malignant condition characterized by increased production of lymphocytes. It has been observed that the cancer first affects B-lymphocytes and then it can spread to other parts of the body. This leukemia is diagnosed mostly at later stages because of the slow buildup of the cancerous cells. During the course of the disease, the malignancy spreads to the spleen, liver, and lymph nodes. The course of the disease is heterogeneous, and prognosis is difficult. Symptoms include swelling of the lymph nodes, fatigue, fever, infection, pain beneath the ribs, and weight loss. Chronic lymphocytic leukemia can be treated with radiation, steroids, chemotherapy, targeted therapy, transplants (bone marrow, stem cell), and surgical procedure to remove the spleen (splenectomy).



Technavio's analysts forecast the global chronic lymphocytic leukemia therapeutics market to grow at a CAGR of 18.52% over the period 2014-2019.



Covered in this Report

In this report, Technavio covers the present scenario and growth prospects of the global chronic lymphocytic leukemia therapeutics market for the period 2015-2019. To calculate the market size, we consider revenue generated from the sales of various drugs used in the treatment of chronic lymphocytic leukemia. 



Based on the type of molecule, we group the market into two categories:

• Biologics

• Small molecules



Based on the route of administration, we group the market into two:

• Oral

• Parenteral



This report includes a discussion of the market in the following three regions: 

• Americas: The major countries focused in the Americas are the US, Canada, Mexico, and Brazil

• EMEA: The major countries in this region are the UK, Germany, Italy, France, Spain and Middle



Eastern and African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE



• APAC: The major countries in this region are Japan, China, Australia, Singapore, South Korea, and India. APAC is a major untapped market with many leading vendors in the global chronic lymphocytic leukemia therapeutics market. 



The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. In addition, it discusses the major drivers and challenges, as well as the key trends.



Key Regions

• Americas

• APAC

• EMEA



Key Vendors

• F. Hoffmann-La Roche

• Novartis 

• Teva Pharmaceutical Industries



Other Prominent Vendors

• Actavis 

• Amgen

• Aryogen 

• Astellas

• Bristol-Myers Squibb

• Eagle Pharmaceuticals 

• Eisai

• Fresenius Kabi

• Genmab

• Gilead Sciences

• H. Lundbeck

• Hospira 

• idd biotech 

• Immunomedics 

• Johnson & Johnson

• Mundipharma

• Mylan

• Noxxon 

• Ono Pharmaceutical

• PDL BioPharma

• Pfizer

• Pharmacyclics

• Regeneron

• Sagent Pharmaceutical

• Sanofi

• SymBio Pharmaceuticals

• TheraMAB 



Key Market Driver

• Increase in Patient Pool

• For a full, detailed list, view our report



Key Market Challenge

• Unknown Disease Etiology

• For a full, detailed list, view our report



Key Market Trend

• Strategic Alliances

• For a full, detailed list, view our report



Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?


Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

European NGS Services Market - Opportunities and Forecasts, 2015 - 2020

Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing. These technologies enable ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390

Read More >>

World Surface Analysis Market - Opportunities and Forecasts, 2014 - 2020

Surface analysis is a technique that provides a medium to correlate performance with thin film conformation. The analysis is used in the discovery of new materials and to enhance the ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Electrophoresis Market - Opportunities and Forecasts, 2015 - 2020

Electrophoresis is a technique used for separation of proteins and nucleic acids. This technique is primarily used for RNA and DNA analysis. It is also used in biochemistry for separation ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Oxidative Stress Assay Market - Opportunities and Forecasts, 2015 - 2020

Oxidative stress assay is used to determine level of oxidative stress markers and reagents in cells. Applications of oxidative stress assay are research laboratories and bioproduction. Assays detect generalized oxidative ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

European Microscopy Market - Opportunities and Forecasts, 2015 - 2020

Microscopy is a field of science in which objects are not visible to bare eye can be viewed under microscope. It is used to observe macromolecules and macromolecular complexes at ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390

Read More >>

World Immunoassay Market - Opportunities and Forecasts, 2015 - 2020

Immunoassay is a test conducted to determine concentration of macromolecule in a solution using antibody or immunoglobulin. The macromolecule detected is known as analyte. Immunoassay is used to measure quantity ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>